Brain Tumours

First page Previous page 919 Next page Last page

Warum molekulare Biomarker? Why molecular biomarkers II ?

Author Division Olaf Witt SIOP LGG 201X

PAge72 1/25/2016 | a

Meta-analysis SIOP LGG pre-clinical working group: ⇒ BRAF KIAA fusions type independent prognostics factor (multivariate analysis: age, location, histology, extend of resection)

Made with